Discovery of Chlorocyclopentadienylbis(triphenylphosphine)ruthenium(II)

If you are hungry for even more, make sure to check my other article about 32993-05-8. Reference of 32993-05-8

Reference of 32993-05-8. Chemistry is an experimental science, and the best way to enjoy it and learn about it is performing experiments.Introducing a new discovery about 32993-05-8, Name is Chlorocyclopentadienylbis(triphenylphosphine)ruthenium(II)

Anticancer activity of the new [Ru(eta5-C5H 5)(PPh3)(Me2bpy)][CF3SO 3] (Me2bpy = 4,4?-dimethyl-2,2?-bipyridine) complex was evaluated in vitro against several human cancer cell lines, namely A2780, A2780CisR, HT29, MCF7, MDAMB231 and PC3. Remarkably, the IC50 values, placed in the nanomolar and sub-micromolar range, largely exceeded the activity of cisplatin. Binding to human serum albumin, either HSA (human serum albumin) or HSAfaf (fatty acid-free human serum albumin) does not affect the complex activity. Fluorescence studies revealed that the present ruthenium complex strongly quench the intrinsic fluorescence of albumin. Cell death by the [Ru(eta5-C5H5)(PPh 3)(Me2bpy)][CF3SO3] complex was reduced in the presence of endocytosis modulators and at low temperature, suggesting an energy-dependent mechanism consistent with endocytosis. On the whole, the biological activity evaluated herein suggests that the complex could be a promising anticancer agent.

If you are hungry for even more, make sure to check my other article about 32993-05-8. Reference of 32993-05-8

Reference:
Highly efficient and robust molecular ruthenium catalysts for water oxidation,
Catalysts | Special Issue : Ruthenium Catalysts – MDPI